BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 24100246)

  • 1. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.
    Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM
    Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of metabolic control and tetrahydrobiopterin treatment on health related quality of life of patients with early-treated phenylketonuria: A PKU-COBESO study.
    Huijbregts SCJ; Bosch AM; Simons QA; Jahja R; Brouwers MCGJ; De Sonneville LMJ; De Vries MC; Hofstede FC; Hollak CEM; Janssen MCH; Langendonk JG; Rubio-Gozalbo ME; Van der Meere JJ; Van der Ploeg AT; Van Spronsen FJ
    Mol Genet Metab; 2018 Sep; 125(1-2):96-103. PubMed ID: 30007854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
    Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
    Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.
    Bosch AM; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Koledova E; Benmedjahed K; Regnault A
    Orphanet J Rare Dis; 2015 Jun; 10():80. PubMed ID: 26084935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
    Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unresponsiveness to tetrahydrobiopterin of phenylalanine hydroxylase deficiency.
    Ponzone A; Porta F; Mussa A; Alluto A; Ferraris S; Spada M
    Metabolism; 2010 May; 59(5):645-52. PubMed ID: 19913839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria.
    Hennermann JB; Bührer C; Blau N; Vetter B; Mönch E
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S86-90. PubMed ID: 16051511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of tetrahydrobiopterin responsive phenylalanine hydroxylase deficiency in southern and northern Chinese patients].
    Yang L; Zhang ZX; Ye J; Zhou ZS; Shen M; Han LS; Qiu W; Yu WM; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):310-3. PubMed ID: 17557244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydrobiopterin treatment in phenylketonuria: A repurposing approach.
    Evers RAF; van Vliet D; van Spronsen FJ
    J Inherit Metab Dis; 2020 Mar; 43(2):189-199. PubMed ID: 31373030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life.
    Ziesch B; Weigel J; Thiele A; Mütze U; Rohde C; Ceglarek U; Thiery J; Kiess W; Beblo S
    J Inherit Metab Dis; 2012 Nov; 35(6):983-92. PubMed ID: 22391997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of BH4-responsiveness in phenylalanine-hydroxylase-deficient Italian patients.
    Fiori L; Fiege B; Riva E; Giovannini M
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S67-74. PubMed ID: 16198137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydrobiopterin responsiveness in patients with phenylketonuria.
    Pérez-Dueñas B; Vilaseca MA; Mas A; Lambruschini N; Artuch R; Gómez L; Pineda J; Gutiérrez A; Mila M; Campistol J
    Clin Biochem; 2004 Dec; 37(12):1083-90. PubMed ID: 15589814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BH4 treatment in BH4-responsive PKU patients: preliminary data on blood prolactin concentrations suggest increased cerebral dopamine concentrations.
    van Vliet D; Anjema K; Jahja R; de Groot MJ; Liemburg GB; Heiner-Fokkema MR; van der Zee EA; Derks TG; Kema IP; van Spronsen FJ
    Mol Genet Metab; 2015 Jan; 114(1):29-33. PubMed ID: 25466353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin.
    Bélanger-Quintana A; García MJ; Castro M; Desviat LR; Pérez B; Mejía B; Ugarte M; Martínez-Pardo M
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S61-6. PubMed ID: 16165389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of Life (QoL) assessment in a cohort of patients with phenylketonuria.
    Cazzorla C; Cegolon L; Burlina AP; Celato A; Massa P; Giordano L; Polo G; Daniele A; Salvatore F; Burlina AB
    BMC Public Health; 2014 Dec; 14():1243. PubMed ID: 25471331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria.
    Erlandsen H; Stevens RC
    J Inherit Metab Dis; 2001 Apr; 24(2):213-30. PubMed ID: 11405341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria.
    Fiege B; Blau N
    J Pediatr; 2007 Jun; 150(6):627-30. PubMed ID: 17517248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year follow-up of B vitamin and Iron status in patients with phenylketonuria provided tetrahydrobiopterin (BH4).
    Brantley KD; Douglas TD; Singh RH
    Orphanet J Rare Dis; 2018 Oct; 13(1):192. PubMed ID: 30373601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience.
    Scala I; Concolino D; Della Casa R; Nastasi A; Ungaro C; Paladino S; Capaldo B; Ruoppolo M; Daniele A; Bonapace G; Strisciuglio P; Parenti G; Andria G
    Orphanet J Rare Dis; 2015 Feb; 10():14. PubMed ID: 25757997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.